INS and type 2 diabetes mellitus: We focus our present study on the human islet amyloid polypeptide (hIAPP or amylin) whose aggregation is thought to cause the loss of the insulin-producing β-cells in type 2 diabetes mellitus.3 The number of adults with type 2 diabetes was estimated to be 347 million in 2011 and has been dramatically rising since then.4